The effect of alogliptin on pulmonary function in obese patients with type 2 diabetes inadequately controlled by metformin monotherapy

BACKGROUND: To observe the effect of alogliptin combined with metformin on pulmonary function in obese patients with type 2 diabetes inadequately controlled by metformin monotherapy (500 mg, bid po, for at least 3 months), and evaluate its efficacy and safety. METHODS: After a 2-week screening perio...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Medicine (Baltimore)
Auteurs principaux: Tai, He, Wang, Ming-Yue, Zhao, Yue-Ping, Li, Ling-Bing, Dong, Qian-Yan, Liu, Xin-Guang, Kuang, Jin-Song
Format: Artigo
Langue:Inglês
Publié: Wolters Kluwer Health 2016
Sujets:
4300
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5370803/
https://ncbi.nlm.nih.gov/pubmed/27537577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000004541
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires